{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:01:41Z","timestamp":1746417701800,"version":"3.40.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Diarrhea-predominant irritable bowel syndrome (D-IBS) is the main subtypes of irritable bowel syndrome (IBS). In recent years, more than half of IBS patients have received complementary and alternative medicine. Traditional Chinese herbal formula is widely used in Asia, and clinical studies have also found that Chinese herbal formula could significantly improve abdominal pain and diarrhea. We plan to carry out a randomized, controlled, double blind, clinical studies to observe the clinical efficacy of Qinghua Zhixie decoction in the treatment of D-IBS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Four hundred sixty-four participants will be randomly assigned to the treatment group and control group. Patients in both groups would take medications and stimulations simultaneously. The outcomes of IBS symptom severity score, quality of life, psychological states, and recurrence rate will be recorded. Statistics will be analyzed with the SPSS 22.0.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The findings of the study will identify the safety and efficacy of Qinghua Zhixie decoction in the treatment of D-IBS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration: OSF Registration number:<\/jats:title>\n            <jats:p>DOI 10.17605\/OSF.IO\/C8MHW.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028895","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T13:04:09Z","timestamp":1646399049000},"page":"e28895","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of Qinghua Zhixie Decoction against diarrhea-predominate irritable bowel syndrome"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4416-8334","authenticated-orcid":false,"given":"Lijiang","family":"Ji","sequence":"first","affiliation":[{"name":"Department of Anorectal Surgery, Changshu Hospital Affiliated to Nanjing University of Chinese Medicine, Changshu, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Zhao","sequence":"additional","affiliation":[{"name":"Tianjin University of Traditional Chinese Medicine, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tianjin University of Traditional Chinese Medicine, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Anorectal Surgery, Changshu Hospital Affiliated to Nanjing University of Chinese Medicine, Changshu, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Gong","sequence":"additional","affiliation":[{"name":"Tianjin University of Traditional Chinese Medicine, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Changshu Hospital Affiliated to Nanjing University of Chinese Medicine, Changshu, Jiangsu Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6111-8019","authenticated-orcid":false,"given":"Hua","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Anorectal Surgery, Changshu Hospital Affiliated to Nanjing University of Chinese Medicine, Changshu, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"07","DOI":"10.2147\/IJGM.S93698","article-title":"Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome","volume":"9","author":"Lacy","year":"2016","journal-title":"Int J Gen Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"04","DOI":"10.1111\/j.1440-1746.2006.04672.x","article-title":"Irritable bowel syndrome in the 21st century: perspectives from Asia or South-east Asia","volume":"22","author":"Chang","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1440-1746.2009.06120.x","article-title":"Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners","volume":"25","author":"Grundmann","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/2327-6924.12387","article-title":"Diarrhea-predominant irritable bowel syndrome: diagnosis, etiology, and new treatment considerations","volume":"28","author":"Lacy","year":"2016","journal-title":"J Am Assoc Nurse Pract"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.gastro.2007.04.005","article-title":"The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects","volume":"133","author":"Kassinen","year":"2007","journal-title":"Gastroenterology"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s10620-009-0934-x","article-title":"A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome","volume":"55","author":"Codling","year":"2010","journal-title":"Dig Dis Sci"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jgh.13987","article-title":"Irritable bowel syndrome in Asia: pathogenesis, natural history, epidemiology, and management","volume":"33","author":"Gwee","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"612","DOI":"10.17235\/reed.2018.5526\/2018","article-title":"Perceptions of the public healthcare system from private-care patients with irritable bowel syndrome with constipation in Spain","volume":"110","author":"Mira","year":"2018","journal-title":"Rev Esp Enferm Dig"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s12272-018-1068-5","article-title":"Recent advances in pharmacological research on the management of irritable bowel syndrome","volume":"41","author":"Yoonjin","year":"2018","journal-title":"Arch Pharm Res"},{"key":"R11-20250504","first-page":"143","article-title":"Complementary and alternative medicine for treatment of irritable bowel syndrome","volume":"55","author":"Shen","year":"2009","journal-title":"Can Fam Physician"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3748\/wjg.v20.i2.346","article-title":"Complementary and alternative medicines in irritable bowel syndrome: an integrative view","volume":"2","author":"Grundmann","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3736\/jcim20090303","article-title":"Effects of Changjishu soft elastic capsule in treatment of diarrhea-predominant irritable bowel patients with liver-qi stagnation and spleen deficiency syndrome: a randomized double-blinded controlled trial","volume":"7","author":"Gao","year":"2009","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s11655-009-0216-7","article-title":"Effect of Tongxie Yaofang Granule in treating diarrhea-predominate irritable bowel syndrome","volume":"15","author":"Pan","year":"2009","journal-title":"Chin J Integr Med"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"4893876","DOI":"10.1155\/2019\/4893876","article-title":"Clinical effects and safety of Tongxieyaofang on diarrhea predominant irritable bowel syndrome: a meta-analysis of randomized trails","volume":"2019","author":"Zhou","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/ptr.5475","article-title":"A randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome","volume":"29","author":"Chen","year":"2015","journal-title":"Phytother Res"},{"key":"R17-20250504","first-page":"772","article-title":"The effect of berberine on intestinal microflora in IBS rats [in Chinese]","volume":"30","author":"Zhou","year":"2018","journal-title":"Chin J Microecol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/ismej.2014.177","article-title":"Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula","volume":"9","author":"Xu","year":"2015","journal-title":"ISME J"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3389\/fphar.2018.01110","article-title":"Tong-Xie-Yao-Fang regulates 5-HT level in diarrhea predominant irritable bowel syndrome through gut microbiota modulation","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"e7586","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress","volume":"11","author":"Francis","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1572-0241.2000.01941.x","article-title":"Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire","volume":"95","author":"Drossman","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br J Soc Clin Psychol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-0327(88)90072-9","article-title":"The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders","volume":"14","author":"Maier","year":"1988","journal-title":"J Affect Disord"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s11655-019-3030-x","article-title":"Post-marketing re-evaluation of Tongxiening Granules in treatment of diarrhea-predominant irritable bowel syndrome: a multi-center, randomized, double-blind, double-dummy and positive control trial","volume":"25","author":"Tang","year":"2019","journal-title":"Chin J Integr Med"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1053\/j.gastro.2014.02.037","article-title":"Brain\u2013Gut microbiome interactions and functional bowel disorders","volume":"146","author":"Mayer","year":"2014","journal-title":"Gastroenterology"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10354-017-0592-0","article-title":"Intestinale Mikrobiom-Darm-Hirn-Achse und Reizdarmsyndrom","volume":"168","author":"Moser","year":"2018","journal-title":"Wien Med Wochenschr"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.coph.2019.04.007","article-title":"The gut microbiome and pharmacology: a prescription for therapeutic targeting of the gut\u2013brain axis","volume":"49","author":"Leprun","year":"2019","journal-title":"Curr Opin Pharmacol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/gut.27.7.826","article-title":"Alternative medicine consultations and remedies in patients with the irritable bowel syndrome","volume":"27","author":"Smart","year":"1986","journal-title":"Gut"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/j.1572-0241.2006.00576.x","article-title":"Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial","volume":"101","author":"Leung","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.3389\/fmicb.2017.02307","article-title":"Wuji Wan formula ameliorates diarrhea and disordered colonic motility in post-inflammation irritable bowel syndrome rats by modulating the gut microbiota","volume":"8","author":"Chen","year":"2017","journal-title":"Front Microbiol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.cgh.2017.06.026","article-title":"Tongxie formula reduces symptoms of irritable bowel syndrome","volume":"15","author":"Fan","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1136\/bmjopen-2017-018362","article-title":"Effect of herbal extract granules combined with otilonium bromide on irritable bowel syndrome with diarrhoea: a study protocol for a randomised controlled trial","volume":"7","author":"Kim","year":"2017","journal-title":"BMJ Open"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3389\/fphar.2020.01210","article-title":"In vivo synergistic effect of berberine-based Chinese medicine assembled nanostructures on diarrhea-predominant irritable bowel syndrome","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/annonc\/mdg343","article-title":"Phase II study of flavopiridol in patients with advanced colorectal cancer","volume":"14","author":"Aklilu","year":"2003","journal-title":"Ann Oncol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.aca.2011.02.046","article-title":"Qualitative and quantitative analysis of chemical constituents in traditional Chinese medicinal formula Tong-Xie-Yao-Fang by high-performance liquid chromatography\/diode array detection\/electrospray ionization tandem mass spectrometry","volume":"691","author":"Yan","year":"2011","journal-title":"Anal Chim Acta"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:05:55Z","timestamp":1746331555000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028895"}},"subtitle":["A protocol for a randomized controlled trial"],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028895","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"2022-02-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}